Workflow
Arcturus Therapeutics Shows Progress Amid Transition: Why I Assign A Hold Rating

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT ) stock is enjoying double-digit gains this month, after rising slightly above 20%. During the COVID boom, the company thrived on large upfront payments and government contracts, driving peak revenues and visibility. Now, that waveGamu Dave Innocent Pasi is a seasoned financial professional and writer, bringing a wealth of experience from his prior roles as a financial analyst and in investment research. With a strong background in analyzing financial statem ...